Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for treating severe alopecia areata.

Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.

A new treatment plan for hair loss combines targeted therapies and regenerative strategies to stabilize, reverse, and maintain hair growth.

Licorice extract helps hair growth and may treat hair loss.

Baricitinib may effectively treat lichen planopilaris.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Platycladi Cacumen may help treat hair loss by affecting certain biological pathways.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Baricitinib is a promising treatment for alopecia areata.

The conclusion is that a treatment called cp-asiAR can reduce hair loss and promote hair growth, making it a potential new therapy for androgenetic alopecia.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Ritlecitinib 50 mg effectively promotes and sustains hair regrowth in alopecia areata patients.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

A new treatment using special nanovesicles with linoleic acid shows promise in improving hair growth and reducing irritation for hair loss.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Agaricus bisporus derived β-Glucan could be an effective cervical cancer treatment with antimicrobial and antioxidant properties.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

Baricitinib effectively treated hair loss and inflammation in a patient with alopecia areata and lichen planopilaris.

New oral treatments for adult hair loss show promise, especially JAK inhibitors, with mild side effects.

Selencin effectively reduces hair loss and improves hair health in diffuse alopecia.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

A new treatment using conjugated linoleic acid in nanovesicles can rejuvenate hair follicles and improve hair growth in androgenic alopecia.